Jose Orlinder Nicolas Zambrano

• Ministerio de Salud de Honduras

Background As Malaria cases are continuously reported across the globe, epidemiological and integral approaches should be considered for an optimal stratification on endemic areas for elimination goal. In Central America, a 75% reduction in malaria incidence has been reported between 2000 and 2015, similarly, in Honduras, more than 75% of total cas...

Elimination of malaria in over 35 countries is a goal for 2030 in the Global Technical Strategy 2015-2030. With this vision, an updated “Framework for Malaria Elimination” has been published by World Health Organization (WHO). Honduras, part of the Regional Initiative for “Elimination of Malaria in Mesoamerica and Island of Hispaniola”, aims to eli...

Chloroquine (CQ) is officially used for the primary treatment of Plasmodium falciparum malaria in Honduras. In this study, the therapeutic efficacy of CQ for the treatment of uncomplicated P. falciparum malaria in the municipality of Puerto Lempira, Gracias a Dios, Honduras was evaluated using the Pan American Health Organization-World Health Organ...

Background: Although LLINs are effective up to 3 to 5 years, a major limiting factor to its prolonged use is the physical durability of the LLIN which depends on a number of human and cultural factors. No data is available for physical durability of LLINs in field conditions in Central American countries which this study explores. Methods: LLINs we...